Is Align Technology Done Disrupting Dental Tech? 

There are 17 3D printing stocks in the Nanalyze Disruptive Tech Stock Catalog. We are avoiding 15 of them outright for various reasons. We currently hold one stock, BICO Group (BICO.ST), a Swedish bioprinting firm that has diversified over the last few years through a series of acquisitions. Investors have not been impressed with the results, despite 78% (mostly inorganic) revenue growth in 2022, driven mainly by all of those new companies. More recently, revenue growth is at a trickle and the remaining founders have exited the company. We may do the same unless the small-cap biotech can hit some key metrics this year that we laid out in our last article.

If we do decide to exit our position, that leaves us just one potential option for a 3D printing stock we still like – Align Technology (ALGN), a dental device company with a current market cap of nearly $17 billion. It’s been nearly seven years since we checked in with this pick-and-shovel play on 3D printing. Let’s dive right in.

Align Revenue Growth Slows

Align Technology is best known for its Invisalign system, a series of clear, removable aligners used to straighten